✦ LIBER ✦

Microwave Thermotherapy for Benign Prostatic Hyperplasia With the Dornier Urowave: Results of a Randomized, Double-Blind, Multicenter, Sham-Controlled Trial

✍ Scribed by Roehrborn, C.G.; Preminger, G.; Newhall, P.; Denstedt, J.; Razvi, H.; Chin, J.; Perlmutter, A.; Barzell, W.; Whitmore, W.; Fritzsch, R.; Sanders, J.; Sech, S.; Womack, S.

Book ID: 123311552
Publisher: Lippincott Williams and Wilkins
Year: 1998
Tongue: English
Weight: 105 KB
Volume: 160
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(01)63117-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Microwave Thermotherapy for Benign Prost

Microwave Thermotherapy for Benign Prostatic Hyperplasia with the Dornier Urowave: Results of a Randomized, Double-blind, Multicenter, Sham-controlled Trial

✍ Claus G Roehrborn; Glenn Preminger; Phil Newhall; John Denstedt; Hassan Razvi; L 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Updated results of a randomized, double-

Updated results of a randomized, double-blind, multicenter sham-controlled trial of microwave thermotherapy with the Dornier Urowave in patients with symptomatic benign prostatic hyperplasia

✍ John Trachtenberg; Claus G. Roehrborn; Urowave Investigators Group 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 470 KB

A High-Efficiency Microwave Thermoablati

A High-Efficiency Microwave Thermoablation System for the Treatment of Benign Prostatic Hyperplasia: Results of a Randomized, Sham-Controlled, Prospective, Double-Blind, Multicenter Clinical Trial

✍ Thayne R Larson; Michael L Blute; Reginald C Bruskewitz; Robert D Mayer; Roland 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 562 KB

Prospective, Randomized, Double-Blind, V

Prospective, Randomized, Double-Blind, Vehicle Controlled, Multicenter Phase IIb Clinical Trial of the Pore Forming Protein PRX302 for Targeted Treatment of Symptomatic Benign Prostatic Hyperplasia

✍ Coplen, D.E. 📂 Article 📅 2013 🏛 Elsevier Science ⚖ 48 KB

Prospective, Randomized, Double-Blind, V

Prospective, Randomized, Double-Blind, Vehicle Controlled, Multicenter Phase IIb Clinical Trial of the Pore Forming Protein PRX302 for Targeted Treatment of Symptomatic Benign Prostatic Hyperplasia

✍ Elhilali, Mostafa M.; Pommerville, Peter; Yocum, Richard C.; Merchant, Rosemina; 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 811 KB

Estrogen reduction by aromatase inhibiti

Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: Results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane

✍ Radlmaier, Albert; Eickenberg, Hans U.; Fletcher, Matthew S.; Fourcade, Richard 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 799 KB

## BACKGROUND. The concept of estrogen withdrawal by an aromatase inhibitor in the treatment of benign prostatic hyperplasia (BPH) was assessed in a prospective, randomized, double-blind, placebo-controlled multicenter trial. METHODS. Two hundred and ninety-two patients with clinical symptoms of B